InVasc is a biotechnology company working toward the discovery and development of novel therapies for the treatment of hypertension, diabetes and vascular diseases.

 

 

  
 
In the News

InVasc Therapeutics Hosts Lt. Governor Fisher During TechColumbus Incubator Tour

American Heart Association Scientific Sessions: November 4-7, 2007 Exhibitor

Georgia Life Sciences Summit 2007, Georgia World Congress Center, Atlanta, GA, October 3, 2007 – Exhibitor

Technology Association of Georgia: TAG Radio, interview with Dr. Bobby Kahn – August 7, 2007

Presentations &
Publications

Seeding Early Stage Research, PharmaVoice, May 2008

Diet Enriched with Oxidized Fatty Acids Lowers Triglyceride Levels in Mice — poster presentation at Arteriosclerosis, Thrombosis and Vascular Annual Conference 2007, American Heart Association

Potential role of statin therapy in heart failure, atrial fibrillation and aortic stenosis. Sameer Nagamia, Martin Thoenes, Qamar A. Khan, Anbu Pandian, Bobby V. Khan
Future Cardiology, November 2006, Vol. 2, No. 6, Pages 687-693

Home | Company | Leadership | Investors & Partners | Research & Development | Drug Pipeline | INV-06 Platform | Contact
 
 
© Copyright InVasc Therapeutics, Inc. 2005-2008. All rights reserved

 

Webdesign by Vantage Media Marketing Inc.